Clinical trial Recruiting at 4 sites Observational

Outcomes of radiofrequency ablation for movement disorders

Official title: Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System

Run by Boston Scientific Corporation · NCT06553625 · Data updated 2026-11-12

This study looks at how well a specific treatment called radiofrequency ablation works for people with movement disorders like Parkinson's disease and essential tremor.

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorBoston Scientific Corporation
Industry-sponsored
Locations4 sites (Cologne and 3 other locations)
StatusRecruiting
StartedJanuary 29, 2024
Main results expectedDecember 2035
Study endsDecember 2035
Registry record updatedOctober 13, 2026
Trial IDNCT06553625 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for treatment with a Boston Scientific RF system for CNS applications who can provide informed consent.

Probably not a fit

Patients with cognitive impairments or other characteristics that limit their ability to assess pain relief or complete study assessments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather real-world outcomes from patients undergoing treatment with Boston Scientific's commercially approved radiofrequency (RF) ablation systems for central nervous system applications. It focuses on conditions such as Parkinson's disease, dystonia, essential tremor, and other movement disorders. Participants will be treated with RF ablation as part of their functional neurosurgery, and their outcomes will be documented to assess the effectiveness of the intervention in a clinical setting.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the effectiveness of RF ablation for treating movement disorders, potentially improving patient care.

How similar studies have gone: Other studies using RF ablation for movement disorders have shown promising results, indicating that this approach has potential.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)
* Signed a valid, IRB/EC/REB-approved informed consent form

Exclusion Criteria:

* Meets any contraindications per locally applicable Directions for Use (DFU)
* Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Where it's running

  • Uniklinik Köln
    Cologne, Germany
    Recruiting
  • Universitaetsklinikum Dusseldorf
    Düsseldorf, Germany
    Recruiting
  • Universitaetsklinikum Wuerzburg
    Würzburg, Germany
    Recruiting
  • St. Georges Hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.